Invention Grant
- Patent Title: Method for activating AMPK and the use of adenine
-
Application No.: US13859741Application Date: 2013-04-10
-
Publication No.: US10335412B2Publication Date: 2019-07-02
- Inventor: Han-Min Chen , Cheng-Yi Kuo , Chun-Fang Huang , Jiun-Tsai Lin
- Applicant: Energenesis Biomedical Co., Ltd.
- Applicant Address: CN New Taipei, Taiwan
- Assignee: ENERGENESIS BIOMEDICAL CO., LTD
- Current Assignee: ENERGENESIS BIOMEDICAL CO., LTD
- Current Assignee Address: CN New Taipei, Taiwan
- Agency: McCarter & English, LLP
- Agent Yu Lu
- Main IPC: A61K31/52
- IPC: A61K31/52
Abstract:
The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.
Public/Granted literature
- US20140309242A1 Method for activating AMPK and the use of Adenine Public/Granted day:2014-10-16
Information query
IPC分类:
